Table 1.
Prevalence of HBV infection in gastric cancer patients and controls.
| Variables | Control (n=930) | Gastric cancer (n=465) | ||||
|---|---|---|---|---|---|---|
| no. (%) | no. (%) | Univariate analysis | Multivariate analysis | |||
| OR (95% CI) | P | OR (95%CI) | P | |||
| Age | 61.42 ± 13.12 | 61.80 ± 10.17 | NA | 0.830 | NA | NA |
| Gender | ||||||
| Female | 478 (51.40) | 129 (27.74) | 1 | 1 | ||
| Male | 452 (48.60) | 336 (72.26) | 2.75 (2.17-3.50) | 0.000 | 2.64 (2.07-3.36) | 0.000 |
| HBsAg | ||||||
| Negative | 862 (92.69) | 404 (86.88) | 1 | 1 | ||
| Positive | 68 (7.31) | 61 (13.12) | 1.91 (1.33-2.76) | 0.001 | 1.62 (1.03-2.55) | 0.039 |
| Anti-HBs | ||||||
| Negative | 436 (46.88) | 213 (45.81) | 1 | 1 | ||
| Positive | 496 (53.12) | 252 (54.19) | 1.04(0.83-1.30) | 0.719 | 1.02 (0.77-1.35) | 0.909 |
| HBeAg | ||||||
| Negative | 928 (99.78) | 463 (99.57) | 1 | 1 | ||
| Positive | 2 (0.22) | 2 (0.43) | 1.00 (0.18-5.47) | 0.999 | 0.84 (0.15-4.78) | 0.839 |
| Anti-HBe | ||||||
| Negative | 727 (63.98) | 242 (52.47) | 1 | 1 | ||
| Positive | 335 (36.02) | 221 (47.53) | 1.46 (1.17-1.83) | 0.001 | 1.23 (0.94-1.61) | 0.139 |
| Anti-HBc | ||||||
| Negative | 489 (52.58) | 203 (43.66) | 1 | 1 | ||
| Positive | 441 (47.42) | 262 (56.34) | 1.43 (1.14-1.79) | 0.002 | 1.28 (1.00-1.64) | 0.047 |
CI, confidence interval; OR, odds ratio; Control, patients admitted to the orthopedics and ear, nose and throat departments of the hospital, unrelated to HBV; NA, not available.
Bold values indicate statistically significant difference.